Refractec's ViewPoint System May Provide Alternative To LASIK Surgery
FDA's Ophthalmic Devices Panel review of Refractec's ViewPoint conductive keratoplasty system to treat spherical hyperopia in patients over 40 has been rescheduled for Nov. 30.
FDA's Ophthalmic Devices Panel review of Refractec's ViewPoint conductive keratoplasty system to treat spherical hyperopia in patients over 40 has been rescheduled for Nov. 30.